Silica nanoparticles (SiNPs) are derived from manufactured materials and the natural
environment, and they cause detrimental effects on human health via various exposure …

The metabolic associated fatty liver disease (MAFLD) is a public health challenge, leading to
a global increase in chronic liver disease. The respiratory exposure of silica nanoparticles …

Amorphous silica nanoparticles (SiNPs) have been widely used and mass-producted due to
its unique properties. With the life cycle of SiNPs-based products, SiNPs are further released …

Quantities of researches have demonstrated silica nanoparticles (SiNPs) exposure
inevitably induced damage to respiratory system, nonetheless, knowledge of its toxicological …

The present study aimed to investigate the mechanisms involved in amorphous silica
nanoparticles (aSiNPs)-mediated hepatotoxicity through the evaluation of changes in global …

Silica nanoparticles (SiNPs) have become one of the most widely studied nanoparticles in
nanotechnology for environmental health and safety. Although many studies have devoted …

The extensive application of silica nanoparticles (SiNPs) brings about inevitable
occupational, environmental, and even iatrogenic exposure for human beings. The liver …

This study aims to assess the effects and the mechanisms of silica nanoparticles (SiNPs) on
hepatotoxicity in both normal and metabolic syndrome mouse models induced by fructose …

Silica nanoparticles (SiO2 NPs) are commonly used in medical and pharmaceutical fields.
Research into the cytotoxicity and overall proteomic changes occurring during initial …

The increase in the usage of silica nanoparticles (SiNPs) in the industrial and medical fields
has raised concerns about their possible adverse effects on human health. The present …